Neogen Co. (NEOG) Shares Bought by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its stake in shares of Neogen Co. (NASDAQ:NEOG) by 13.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,374 shares of the company’s stock after acquiring an additional 1,463 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Neogen were worth $885,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of NEOG. Tower Research Capital LLC TRC bought a new stake in shares of Neogen during the second quarter valued at approximately $106,000. Acadian Asset Management LLC bought a new stake in shares of Neogen during the third quarter valued at approximately $275,000. Granahan Investment Management Inc. MA bought a new stake in shares of Neogen during the second quarter valued at approximately $283,000. Everence Capital Management Inc. raised its stake in shares of Neogen by 26.0% during the third quarter. Everence Capital Management Inc. now owns 3,973 shares of the company’s stock valued at $284,000 after acquiring an additional 820 shares in the last quarter. Finally, Carlson Capital Management bought a new stake in shares of Neogen during the third quarter valued at approximately $306,000. 87.79% of the stock is owned by hedge funds and other institutional investors.

Shares of NEOG stock opened at $64.86 on Friday. The company has a market cap of $3.37 billion, a P/E ratio of 53.60 and a beta of 1.40. Neogen Co. has a 52-week low of $54.09 and a 52-week high of $97.38.

Neogen (NASDAQ:NEOG) last issued its quarterly earnings data on Tuesday, September 25th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.28 by $0.01. The company had revenue of $99.60 million for the quarter, compared to analyst estimates of $104.43 million. Neogen had a net margin of 16.35% and a return on equity of 12.06%. Neogen’s revenue was up 5.7% compared to the same quarter last year. During the same period last year, the company posted $0.31 earnings per share. As a group, equities analysts predict that Neogen Co. will post 1.24 EPS for the current year.

Neogen declared that its board has initiated a stock buyback program on Wednesday, October 10th that permits the company to repurchase 3,000,000 outstanding shares. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are usually a sign that the company’s management believes its shares are undervalued.

In other Neogen news, Director James P. Tobin acquired 500 shares of the business’s stock in a transaction that occurred on Wednesday, September 26th. The shares were bought at an average cost of $73.37 per share, with a total value of $36,685.00. Following the completion of the acquisition, the director now directly owns 4,766 shares in the company, valued at approximately $349,681.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO John Edward Adent acquired 4,300 shares of the business’s stock in a transaction that occurred on Wednesday, September 26th. The shares were acquired at an average cost of $73.58 per share, for a total transaction of $316,394.00. Following the completion of the acquisition, the chief executive officer now owns 4,300 shares of the company’s stock, valued at $316,394. The disclosure for this purchase can be found here. Over the last three months, insiders have sold 72,851 shares of company stock worth $4,482,628. 3.00% of the stock is currently owned by corporate insiders.

Several brokerages recently issued reports on NEOG. Zacks Investment Research raised shares of Neogen from a “sell” rating to a “hold” rating in a report on Monday, November 26th. BidaskClub raised shares of Neogen from a “sell” rating to a “hold” rating in a report on Tuesday, November 13th. Finally, ValuEngine lowered shares of Neogen from a “strong-buy” rating to a “buy” rating in a report on Wednesday, September 26th. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Neogen presently has an average rating of “Hold” and an average price target of $67.75.

TRADEMARK VIOLATION NOTICE: “Neogen Co. (NEOG) Shares Bought by Commonwealth of Pennsylvania Public School Empls Retrmt SYS” was posted by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://www.com-unik.info/2018/12/02/neogen-co-neog-shares-bought-by-commonwealth-of-pennsylvania-public-school-empls-retrmt-sys.html.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.

Read More: Risk Tolerance and Your Investment Decisions

Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Co. (NASDAQ:NEOG).

Institutional Ownership by Quarter for Neogen (NASDAQ:NEOG)

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit